Collectively, we established a predictive diagnosis model for NSCLC BM which showed that the combined analysis of serum CTSF and FBLN1 levels may facilitate the diagnosis of NSCLC BM. This evidence concerns the gene CTSF and non-small cell lung carcinoma.